- Home
- WDC vs ILMN Comparison
WDC vs ILMN Comparison
Compare WDC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDC
- ILMN
- Stock Information
- Founded
- WDC 1970
- ILMN 1998
- Country
- WDC United States
- ILMN United States
- Employees
- WDC N/A
- ILMN N/A
- Industry
- WDC Electronic Components
- ILMN Medical Specialities
- Sector
- WDC Technology
- ILMN Health Care
- Exchange
- WDC Nasdaq
- ILMN Nasdaq
- Market Cap
- WDC 18.1B
- ILMN 13.1B
- IPO Year
- WDC N/A
- ILMN 2000
- Fundamental
- Price
- WDC $66.14
- ILMN $99.25
- Analyst Decision
- WDC Buy
- ILMN Buy
- Analyst Count
- WDC 22
- ILMN 17
- Target Price
- WDC $70.86
- ILMN $124.35
- AVG Volume (30 Days)
- WDC 6.4M
- ILMN 2.4M
- Earning Date
- WDC 07-30-2025
- ILMN 07-31-2025
- Dividend Yield
- WDC 0.60%
- ILMN N/A
- EPS Growth
- WDC N/A
- ILMN N/A
- EPS
- WDC 4.55
- ILMN N/A
- Revenue
- WDC $15,605,000,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- WDC N/A
- ILMN N/A
- Revenue Next Year
- WDC $8.21
- ILMN $3.15
- P/E Ratio
- WDC $14.54
- ILMN N/A
- Revenue Growth
- WDC 123.41
- ILMN N/A
- 52 Week Low
- WDC $28.83
- ILMN $68.70
- 52 Week High
- WDC $66.83
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- WDC 77.26
- ILMN 65.51
- Support Level
- WDC $63.67
- ILMN $95.09
- Resistance Level
- WDC $66.83
- ILMN $101.28
- Average True Range (ATR)
- WDC 1.50
- ILMN 3.28
- MACD
- WDC -0.18
- ILMN 0.10
- Stochastic Oscillator
- WDC 91.55
- ILMN 78.82
About WDC Western Digital Corporation
Western Digital is a leading, vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly with, Western Digital and Seagate being the two largest players. Western Digital designs and manufacturers its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.